ENDOLOGIX INC's ticker is ELGX and the CUSIP is 29266S106. A total of 125 filers reported holding ENDOLOGIX INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $76,000 | -10.6% | 17,000 | -2.3% | 0.00% | -25.0% |
| Q2 2017 | $85,000 | -32.5% | 17,400 | 0.0% | 0.00% | -33.3% |
| Q1 2017 | $126,000 | +26.0% | 17,400 | 0.0% | 0.01% | +20.0% |
| Q4 2016 | $100,000 | -55.2% | 17,400 | 0.0% | 0.01% | -58.3% |
| Q3 2016 | $223,000 | -17.4% | 17,400 | -19.6% | 0.01% | -20.0% |
| Q2 2016 | $270,000 | +49.2% | 21,650 | 0.0% | 0.02% | +36.4% |
| Q1 2016 | $181,000 | -8.1% | 21,650 | 0.0% | 0.01% | -15.4% |
| Q4 2015 | $197,000 | -14.0% | 21,650 | +16.1% | 0.01% | -13.3% |
| Q3 2015 | $229,000 | -9.1% | 18,650 | +13.7% | 0.02% | -6.2% |
| Q2 2015 | $252,000 | -10.0% | 16,400 | 0.0% | 0.02% | -15.8% |
| Q1 2015 | $280,000 | +11.6% | 16,400 | 0.0% | 0.02% | +11.8% |
| Q4 2014 | $251,000 | +44.3% | 16,400 | 0.0% | 0.02% | +41.7% |
| Q3 2014 | $174,000 | -30.1% | 16,400 | 0.0% | 0.01% | -33.3% |
| Q2 2014 | $249,000 | +18.0% | 16,400 | 0.0% | 0.02% | +5.9% |
| Q1 2014 | $211,000 | -24.4% | 16,400 | +2.5% | 0.02% | -39.3% |
| Q4 2013 | $279,000 | +8.1% | 16,000 | 0.0% | 0.03% | -6.7% |
| Q3 2013 | $258,000 | +21.7% | 16,000 | 0.0% | 0.03% | +3.4% |
| Q2 2013 | $212,000 | – | 16,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|